1 – 10 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
- 2016
-
Mark
Imaging nigrostriatal circuitry with 11C-PE2I PET and Neuromelanin-sensitive MR in Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
(
- Contribution to conference › Abstract
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
Clinical neurotransplantation: Core assessment protocol rather than sham surgery as control
(
- Contribution to journal › Scientific review
-
Mark
Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L.
(
- Contribution to journal › Article
- 2001
-
Mark
Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats
(
- Contribution to journal › Article
-
Mark
Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion
(
- Contribution to journal › Article